Article metrics

Download PDFPDF

Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: July 2017 to July 2019

AbstractFullPdf
Jul 2017414113
Aug 2017464722
Sep 2017313111
Oct 2017393918
Nov 2017505017
Dec 2017535326
Jan 2018404014
Feb 2018474717
Mar 2018787224
Apr 2018696940
May 2018686923
Jun 2018636318
Jul 201812011821
Aug 201813113129
Sep 201812612525
Oct 201814014029
Nov 201813313317
Dec 2018616120
Jan 2019646221
Feb 2019747425
Mar 2019818132
Apr 2019525215
May 2019777627
Jun 2019535318
Jul 2019646517
Total18011792539